Skip To Main Content
Rajneesh Nath on Muck Rack

Rajneesh Nath

As seen in: Nature, The Lancet, Texas Medical Center, Targeted Oncology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Rajneesh Nath’s profile

Articles by Rajneesh Nath

A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial

|
By Doris M. Ponce, Zachariah DeFilipp, Christopher Ford, Mary-Jane Lombardo, David Lichter, Meghan E. Chafee, Satyajit Kosuri, Nandita Khera, Hemant S. Murthy, Karamjeet S. Sandhu, David N. Fredricks, Tessa M. Andermann, Rajneesh Nath, Kelly Brady, Brooke R. Hasson, Emily Walsh, Nathan D. Hicks, Jonathan Peled, Lisa von Moltke, Matthew R. Henn, Marcel R. M. van den Brink, Bina Tejura, Dennis M. Walling
| Nature Verified
Abstract Gastrointestinal (GI) microbiome disruption and impaired GI barrier integrity increase the risk of bloodstream infection (BSI) following allogeneic hematopoietic cell transplant.
Open in Who Shared Issue with article?

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

|
By Michael Byrne, Zheng Zhou, Rajneesh Nath, Jan Černý
| Texas Medical Center
Keywords Adult, Busulfan, Hematopoietic Stem Cell Transplantation, Humans, Leukemia, Myeloid, Acute, Melphalan, Transplantation Conditioning Abstract There is a lack of large comparative study on the outcomes of reduced intensity conditioning (RIC) in acute myeloid leukemia (AML) transplantation using fludarabine/busulfan (FB) and fludarabine/melphalan (FM) regimens.
Open in Who Shared Issue with article?
Show More